Delivery Order SPE2DB22D3501-SPE2DB25FVW49
Award Date 5/30/25
Potential Completion Date 6/2/25
Potential Value $4.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $33,974.03 by the Defense Logistics Agency (DLA) on August 5, 2025, with an ultimate completion date of August 6, 2025. The delivery order, awarded under firm fixed-price terms with no set-aside designation, calls for the supply of Enbrel 50 mg/mL syringes. This award represents a child contract executed under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 7, 2025, valued at $15,430.07 for the supply of Enbrel 50 mg/ml syringes. The contract is a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and carries no set-aside designation. This award was issued by the Defense Logistics Agency's Medical Supply Chain division and represents a competitively awarded contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $32,961.43 by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injectors. The contract carries a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. The delivery order is scheduled for completion by August 19, 2025, and will be...
- The U.S. Defense Logistics Agency (DLA) awarded a $11,537.80 firm-fixed price Delivery Order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of ENBREL 50 MG/ML syringes and has a completion date of September 5, 2024. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of essential medical commodities to various federal agencies, including the military. This contract award is part of AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $5,486 delivery order on July 24, 2025, for Enbrel 25 mg/0.5 mL syringes under a firm fixed price contract type with no set-aside designation. The order, designated as a child contract action, is set for completion by July 25, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $9,806.98 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml syringes, with an ultimate completion date of September 17, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The contract was executed on September 16, 2025, with performance to be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility, the company's corporate headquarters....
- The Defense Logistics Agency awarded a $14.5K delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of ENBREL 25 mg/0.5 ml syringes. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $58,286.34 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Enbrel 50 mg/mL syringes. The contract employs firm fixed pricing with no set-aside designation and is scheduled for completion by August 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,030.79 for Enbrel 25 mg/0.5 mL syringes on July 29, 2025, with completion targeted for July 30, 2025. This firm fixed-price contract, with no set-aside designation, represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,677.38 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL syringes, with performance in Conshohocken, Pennsylvania and completion targeted for September 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. This delivery order is issued under...